from American Society For Transplantation And Cellular Therapy
Corey Cutler, MD, MPH Named 2024-2025 President of ASTCT
CHICAGO, IL / ACCESSWIRE / February 27, 2024 / The American Society for Transplantation and Cellular Therapy® (ASTCT®) announced Corey Cutler, MD, MPH as the President of the Society in 2024-2025. Dr. Cutler first served on the Board of Directors in 2009 and has been a member of ASTCT since 2002.
Corey Cutler, MD, MPH Named 2024-2025 President of ASTCT.
Dr. Cutler is the Director of Adult Stem Cell Transplantation Program at Dana-Farber Cancer Institute in Boston and a Professor of Medicine at Harvard Medical School.
"I am honored to take over this role and build on the successful foundation that my predecessors have established," stated Dr. Cutler. In my role as President of ASTCT, I will advocate for our patients and support our field by advancing science and education for our community."
Prior to his time on the ASTCT Board of Directors, Dr. Cutler served the Society as the Chair of the Task Force on Generic Drugs in Stem Cell Transplantation and as Chair of the Committee on Young Clinicians and Investigators and was an inaugural faculty member for the ASTCT Clinical Research Training Course.
Dr. Cutler earned an MPH degree at the Harvard School of Public Health. He served as the chair of the CIBMTR Nominating Committee and is an editorial board member for the journal Biology of Blood and Marrow Transplantation.
Dr. Cutler's research focuses on the development of novel methods of acute and chronic graft-vs-host disease prophylaxis and therapy, and decision theory in stem cell transplantation. He has been a contributing author on more than 300 peer-reviewed publications and 25 reviews and book chapters.
In addition to Dr. Cutler, below is the complete list of 2024-2025 ASTCT Board of Directors:
Corey Cutler, MD, MPH (Dana-Farber Cancer Institute), President
David Porter, MD (University of Pennsylvania), President Elect
Margaret MacMillan, MD, MSc, FRCPC (University of Minnesota), Vice President
Mehdi Hamadani, MD (Medical College of Wisconsin), Secretary
Eneida Nemecek, MD, MBA (Oregon Health & Science University), Treasurer
Miguel-Angel Perales, MD (Memorial Sloan Kettering Cancer Center), Immediate Past President
Alan Hanash, MD, PhD (Memorial Sloan Kettering Cancer Center), Directors of Laboratory Science
Sung-Yun Pai, MD (National Institute of Health), Directors of Laboratory Science
Sophie Paczesny, MD, PhD (Medical University of South Carolina), Directors of Laboratory Science
Nandita Khera, MD, MPH (Mayo Clinic), Directors of Community or Clinical Practice
Dianna Howard, MD (Atrium Health Wake Forest Baptist), Directors of Community or Clinical Practice
Ryotaro Nakamura, MD (City of Hope), Directors of Community or Clinical Practice
Lori Muffly, MD, MS (Stanford University), Directors at Large
Nirali Shah, MD, MHSc (National Institute of Health), Directors at Large
Claudio Brunstein, MD (Cleveland Clinic), Directors at Large
Robert Korngold, PhD (Emeritus), Ex-Officio Directors
Alison Gulbis, PharmD, BCOP (MD Anderson), Ex-Officio Directors
Misty Evans, DNP APRN CPNP-AC BMTCN® (Vanderbilt/Sarah Cannon), Ex-Officio Directors
Contact Information
Jennifer Kasowicz
ASTCT Marketing Director
jkasowicz@astct.org
(312) 673-4970
SOURCE: American Society for Transplantation and Cellular Therapy (ASTCT)
View the original press release on newswire.com.